Off-label use of contrast agents

European Radiology

Volumn 18, Issue 6, 2008, Pages 1096-1101

  Reimer, Peter ^a   Vosshenrich, R ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Radiology Group   (Germany)

Author keywords

Contrast media; Label; Off label

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOFOSVESET; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; GADOTERIDOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ARTICLE; CHILD CARE; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG LABELING; DRUG LEGISLATION; DRUG MONITORING; DRUG QUALITY; EUROPEAN UNION; HUMAN; LEGAL ASPECT; LEGAL LIABILITY; MEDICAL ETHICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF LABEL DRUG USE; PATIENT SAFETY; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

CONTRAST MEDIA; DRUG LABELING; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; PHYSICIAN'S PRACTICE PATTERNS;

EID: 43449088825     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-0886-0     Document Type: Article

References (27)